AtaiBeckley Inc.
7.29USD
+0.0100 (+0.14%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.12▼ | $-0.12 | 0 | 2 |
| Next quarter | $-0.13▼ | $-0.13 | 0 | 2 |
| Current year | $-0.43▲ | $-0.43 | 1 | 2 |
| Next year | $-0.49▼ | $-0.46 | 2 | 1 |
Beat in 1 of the last 3
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.11 | $-0.09 | +0.02 (+19.4%) |
| 2025-12-31 | $-0.11 | $-1.73 | -1.62 (-1441.6%) |
| 2025-09-30 | $-0.12 | $-0.28 | -0.16 (-125.3%) |
31 ratings from 9 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Deutsche Bank | Downgraded from Buy | Hold | $12 $8 | Aug 12, 2026 |
| HC Wainwright & Co. | Downgraded from Buy | Neutral | $25 $7.5 | Jul 20, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Jul 17, 2026 |
| Jones Trading | Downgraded from Buy | Hold | — | Jul 17, 2026 |
| Jefferies | Downgraded from Buy | Hold | $10 $7.5 | Jul 17, 2026 |
| Maxim Group | Downgraded from Buy | Hold | — | Jul 16, 2026 |
| Canaccord Genuity | Downgraded from Buy | Hold | $8 | Jul 16, 2026 |
| Needham | Downgraded from Buy | Hold | — | Jul 16, 2026 |
| Canaccord Genuity | Maintained | Buy | $15 $17 | Jul 7, 2026 |
| Jefferies | Maintained | Buy | $10 | Jul 6, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $25 | Jun 8, 2026 |
| Canaccord Genuity | Maintained | Buy | $14 $15 | Apr 20, 2026 |
| Guggenheim | Maintained | Buy | $11 $16 | Apr 17, 2026 |
| Deutsche Bank | Initiated | Buy | $12 | Mar 27, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $25 | Mar 17, 2026 |
| Needham | Reiterated | Buy | $14 | Mar 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $15 $25 | Mar 2, 2026 |
| Guggenheim | Initiated | Buy | $11 | Jan 20, 2026 |
| Jones Trading | Initiated | Buy | $16 | Dec 23, 2025 |
| Canaccord Genuity | Maintained | Buy | $11 $14 | Oct 22, 2025 |
| Needham | Initiated | Buy | $12 | Oct 13, 2025 |
| HC Wainwright & Co. | Reiterated | Buy | $15 | Sep 23, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $10 $15 | Jul 30, 2025 |
| Oppenheimer | Initiated | Outperform | $14 | Jul 29, 2025 |
| Canaccord Genuity | Maintained | Buy | $12 $11 | Jul 28, 2025 |
27 filings from 10 insiders · 6 buy / 5 sell over 6m
Officers and directors of ATAI, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| HERSHBERG ROBERT MDirector | Exercise | 100.0k | $1.35 | $135k | Jul 7, 2026 |
| HERSHBERG ROBERT MDirector | Sell | 100.0k | $4.96 | $496k | Jul 7, 2026 |
| KOCHENDOERFER GREDChief Operating Officer | Exercise | 50.0k | $1.60 | $80k | Jun 26, 2026 |
| KOCHENDOERFER GREDChief Operating Officer | Sell | 50.0k | $5.00 | $250k | Jun 26, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Exercise | 42.6k | $1.18 | $61k | Jun 25, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Sell | 42.6k | $4.51 | $192k | Jun 25, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Exercise | 42.6k | $1.50 | $69k | Apr 20, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Sell | 42.6k | $5.00 | $213k | Apr 20, 2026 |
| ANGERMAYER CHRISTIANDirector and Beneficial Owner of more than 10% of a Class of Security | Exercise | 559.2k | $1.34 | $897k | Apr 8, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Exercise | 100.0k | $1.18 | $126k | Mar 20, 2026 |
| CRAIG KEVIN JAMES M.D.Officer | Sell | 100.0k | $3.55 | $355k | Mar 20, 2026 |
| FEILDING-MELLEN COSMODirector | Sell | 39.6k | $3.90 | $154k | Jan 2, 2026 |
| FEILDING-MELLEN COSMODirector | Other | 7.70M | — | — | Nov 5, 2025 |
| APEIRON INVESTMENT GROUP LTD.Beneficial Owner of more than 10% of a Class of Security | Otherindirect | 2.37M | — | — | Sep 30, 2025 |
| APEIRON INVESTMENT GROUP LTD.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 8.68M | $2.19 | $19.00M | Aug 14, 2025 |
| APEIRON INVESTMENT GROUP LTD.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 1.80M | $1.40 | $2.52M | Mar 24, 2025 |
| RAO SRINIVASChief Executive Officer | Sell | 75.4k | $1.35 | $102k | Mar 21, 2025 |
| KIRPEKAR SAHILOfficer | Sell | 48.6k | $1.35 | $66k | Mar 21, 2025 |
| JOHNSON ANNE NAGENGASTChief Financial Officer | Sell | 33.5k | $1.35 | $45k | Mar 21, 2025 |
| CRAIG KEVIN JAMES M.D.Officer | Sell | 11.6k | $1.35 | $16k | Mar 21, 2025 |
No analyst notes on ATAI yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 1 | 13 | 0 | 0 | Hold2.93 |
| 1 mo ago | 0 | 3 | 11 | 0 | 0 | Hold2.79 |
| 2 mo ago | 2 | 12 | 0 | 0 | 0 | Buy1.86 |